|
Volumn 108, Issue 2, 2001, Pages 348-366
|
Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma: I. Visual acuity after 3 years, COMS Report No. 16
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
IODINE 125;
ADULT;
AGED;
ARTICLE;
BRACHYTHERAPY;
CHOROID CANCER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
ENUCLEATION;
FEMALE;
FOLLOW UP;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MELANOMA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RETINA DETACHMENT;
RETINA FOVEA;
RISK FACTOR;
TREATMENT OUTCOME;
TUMOR VOLUME;
VISUAL ACUITY;
ADULT;
AGED;
AGED, 80 AND OVER;
BRACHYTHERAPY;
CHOROID NEOPLASMS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IODINE RADIOISOTOPES;
LIFE TABLES;
MALE;
MELANOMA;
MIDDLE AGED;
PROSPECTIVE STUDIES;
VISUAL ACUITY;
|
EID: 0035153825
PISSN: 01616420
EISSN: None
Source Type: Journal
DOI: 10.1016/S0161-6420(00)00526-1 Document Type: Article |
Times cited : (293)
|
References (36)
|